Michael D West
AgeX Therapeutics, USA
Biography
Dr. West is Co-Chief Executive Officer of BioTime, Inc. (NYSE MKT: BTX) and CEO of BioTime’s subsidiary AgeX Therapeutics, Inc. BioTime is focused on developing an array of research and therapeutic products using pluripotent stem cell technology. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He was the founder and first CEO of Geron Corporation of Menlo Park, California (Nasdaq: GERN), held positions as CEO, President, and Chief Scientific Officer at Advanced Cell Technology, Inc., which was acquired by Astellas Pharma, Inc., and founded Asterias Biotherapeutics (NYSE MKT: AST).